Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.

Neogen Corporation

Neogen (($NEOG)) has held its Q4 earnings call. Read on for the main highlights of the call. Neogen’s latest earnings call struck a cautiously upbe...

Neogen Earnings Call Highlights Growth, Investment Trade-offs

Neogen (NEOG) has disclosed a new risk, in the Accounting & Financial Operations category. Neogen has remediated past material weaknesses, but its ...

Neogen’s Evolving Business Model Keeps Internal Controls a Key Financial Risk

William Blair analyst Brandon Vazquez assigned a Hold rating to the stock yesterday. The company’s shares closed yesterday at $9.34. Vazquez covers...

William Blair Gives a Hold Rating to Neogen (NEOG)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neogen (NEOG) and Cardinal Health (CAH). Neogen (NEOG) William Bl...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG) and Cardinal Health (CAH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neogen (NEOG) and Cardinal Health (CAH). Neogen (N...

Analysts Offer Insights on Healthcare Companies: Neogen (NEOG) and Cardinal Health (CAH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cardinal Health (CAH) and Neogen (NEOG). Cardinal ...

Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH) and Neogen (NEOG)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardinal Health (CAH) and Neogen (NEOG)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Palvella Therapeutics (PVLA), Neogen (NEOG) and ACADIA Pharmaceut...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NEOG	$11.65	0.00%	1.65M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NEOG	$11.65	0%	1.65M
3
4
5
6

NEOG

Get Neogen Corporation Data in Excel

Get Neogen Corporation Data in Excel